Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
no AE; 9-month-old vaccinated with MMR; 9-month old child was inadvertently vaccinated with mmr while on dupilumab; This spontaneous report was received from an other health professional and refers to a 9-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 12-MAY-2025, the patient started therapy with dupilumab (DUPIXENT) solution for injection (strength, dose, frequency, route of administration, indication, expiration date, and lot # were not reported). On 23-MAY-2025, the patient was inadvertently vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) injection (reported as "MMR vaccine"), administered for prophylaxis (dose, route of administration, anatomical location, lot # and expiration date were not reported) while on dupilumab (DUPIXENT) without presciber's knowledge (Product administered to patient of inappropriate age, Contraindicated product administered). The vaccine was reconstituted with sterile diluent (lot# and expiration date not reported). No adverse event was reported. Action taken with dupilumab (DUPIXENT) was reported as dose not changed. Lot# is being requested and will be submitted if received.
Dupixent; sterile diluent